4/A//SEC Filing
Sharp John P 4/A
Accession 0001169245-21-000087
CIK 0001169245other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:41 PM ET
Size
7.2 KB
Accession
0001169245-21-000087
Insider Transaction Report
Form 4/AAmended
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-08-03−7,500→ 98,082 totalExercise: $1.68From: 2020-04-11Exp: 2026-05-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2021-08-03$1.68/sh+7,500$12,600→ 50,224 total
Footnotes (3)
- [F1]Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on August 3, 2021.
- [F2]Amended to add a transaction for the exercise of stock options on August 3, 2021.
- [F3]All shares underlying this option have vested.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001342894
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:41 PM ET
- Size
- 7.2 KB